IBDEI07P ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7621,1,4,0)
 ;;=4^Z85.038
 ;;^UTILITY(U,$J,358.3,7621,2)
 ;;=^5063399
 ;;^UTILITY(U,$J,358.3,7622,0)
 ;;=Z85.048^^42^499^97
 ;;^UTILITY(U,$J,358.3,7622,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7622,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Rectum,Rectosig Junct & Anus
 ;;^UTILITY(U,$J,358.3,7622,1,4,0)
 ;;=4^Z85.048
 ;;^UTILITY(U,$J,358.3,7622,2)
 ;;=^5063401
 ;;^UTILITY(U,$J,358.3,7623,0)
 ;;=Z85.118^^42^499^86
 ;;^UTILITY(U,$J,358.3,7623,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7623,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Bronchus & Lung
 ;;^UTILITY(U,$J,358.3,7623,1,4,0)
 ;;=4^Z85.118
 ;;^UTILITY(U,$J,358.3,7623,2)
 ;;=^5063408
 ;;^UTILITY(U,$J,358.3,7624,0)
 ;;=Z85.21^^42^499^91
 ;;^UTILITY(U,$J,358.3,7624,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7624,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Larynx
 ;;^UTILITY(U,$J,358.3,7624,1,4,0)
 ;;=4^Z85.21
 ;;^UTILITY(U,$J,358.3,7624,2)
 ;;=^5063411
 ;;^UTILITY(U,$J,358.3,7625,0)
 ;;=Z85.3^^42^499^85
 ;;^UTILITY(U,$J,358.3,7625,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7625,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Breast
 ;;^UTILITY(U,$J,358.3,7625,1,4,0)
 ;;=4^Z85.3
 ;;^UTILITY(U,$J,358.3,7625,2)
 ;;=^5063416
 ;;^UTILITY(U,$J,358.3,7626,0)
 ;;=Z85.41^^42^499^87
 ;;^UTILITY(U,$J,358.3,7626,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7626,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Cervix Uteri
 ;;^UTILITY(U,$J,358.3,7626,1,4,0)
 ;;=4^Z85.41
 ;;^UTILITY(U,$J,358.3,7626,2)
 ;;=^5063418
 ;;^UTILITY(U,$J,358.3,7627,0)
 ;;=Z85.43^^42^499^95
 ;;^UTILITY(U,$J,358.3,7627,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7627,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Ovary
 ;;^UTILITY(U,$J,358.3,7627,1,4,0)
 ;;=4^Z85.43
 ;;^UTILITY(U,$J,358.3,7627,2)
 ;;=^5063420
 ;;^UTILITY(U,$J,358.3,7628,0)
 ;;=Z85.46^^42^499^96
 ;;^UTILITY(U,$J,358.3,7628,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7628,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Prostate
 ;;^UTILITY(U,$J,358.3,7628,1,4,0)
 ;;=4^Z85.46
 ;;^UTILITY(U,$J,358.3,7628,2)
 ;;=^5063423
 ;;^UTILITY(U,$J,358.3,7629,0)
 ;;=Z85.47^^42^499^100
 ;;^UTILITY(U,$J,358.3,7629,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7629,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Testis
 ;;^UTILITY(U,$J,358.3,7629,1,4,0)
 ;;=4^Z85.47
 ;;^UTILITY(U,$J,358.3,7629,2)
 ;;=^5063424
 ;;^UTILITY(U,$J,358.3,7630,0)
 ;;=Z85.51^^42^499^84
 ;;^UTILITY(U,$J,358.3,7630,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7630,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Bladder
 ;;^UTILITY(U,$J,358.3,7630,1,4,0)
 ;;=4^Z85.51
 ;;^UTILITY(U,$J,358.3,7630,2)
 ;;=^5063428
 ;;^UTILITY(U,$J,358.3,7631,0)
 ;;=Z85.528^^42^499^89
 ;;^UTILITY(U,$J,358.3,7631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7631,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Kidney
 ;;^UTILITY(U,$J,358.3,7631,1,4,0)
 ;;=4^Z85.528
 ;;^UTILITY(U,$J,358.3,7631,2)
 ;;=^5063430
 ;;^UTILITY(U,$J,358.3,7632,0)
 ;;=Z85.6^^42^499^80
 ;;^UTILITY(U,$J,358.3,7632,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7632,1,3,0)
 ;;=3^Personal Hx of Leukemia
 ;;^UTILITY(U,$J,358.3,7632,1,4,0)
 ;;=4^Z85.6
 ;;^UTILITY(U,$J,358.3,7632,2)
 ;;=^5063434
 ;;^UTILITY(U,$J,358.3,7633,0)
 ;;=Z85.72^^42^499^104
 ;;^UTILITY(U,$J,358.3,7633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7633,1,3,0)
 ;;=3^Personal Hx of Non-Hodgkin Lymphomas
 ;;^UTILITY(U,$J,358.3,7633,1,4,0)
 ;;=4^Z85.72
 ;;^UTILITY(U,$J,358.3,7633,2)
 ;;=^5063436
 ;;^UTILITY(U,$J,358.3,7634,0)
 ;;=Z85.79^^42^499^94
 ;;^UTILITY(U,$J,358.3,7634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7634,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Lymphoid,Hematpoetc & Rel Tissue
 ;;^UTILITY(U,$J,358.3,7634,1,4,0)
 ;;=4^Z85.79
 ;;^UTILITY(U,$J,358.3,7634,2)
 ;;=^5063437
 ;;^UTILITY(U,$J,358.3,7635,0)
 ;;=Z85.820^^42^499^83
 ;;^UTILITY(U,$J,358.3,7635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7635,1,3,0)
 ;;=3^Personal Hx of Malig Melanoma of Skin
 ;;^UTILITY(U,$J,358.3,7635,1,4,0)
 ;;=4^Z85.820
 ;;^UTILITY(U,$J,358.3,7635,2)
 ;;=^5063441
 ;;^UTILITY(U,$J,358.3,7636,0)
 ;;=Z85.828^^42^499^98
 ;;^UTILITY(U,$J,358.3,7636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7636,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Skin
 ;;^UTILITY(U,$J,358.3,7636,1,4,0)
 ;;=4^Z85.828
 ;;^UTILITY(U,$J,358.3,7636,2)
 ;;=^5063443
 ;;^UTILITY(U,$J,358.3,7637,0)
 ;;=Z85.71^^42^499^78
 ;;^UTILITY(U,$J,358.3,7637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7637,1,3,0)
 ;;=3^Personal Hx of Hodgkin Lymphoma
 ;;^UTILITY(U,$J,358.3,7637,1,4,0)
 ;;=4^Z85.71
 ;;^UTILITY(U,$J,358.3,7637,2)
 ;;=^5063435
 ;;^UTILITY(U,$J,358.3,7638,0)
 ;;=Z65.8^^42^499^138
 ;;^UTILITY(U,$J,358.3,7638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7638,1,3,0)
 ;;=3^Psychosocial Circumstance Related Problems
 ;;^UTILITY(U,$J,358.3,7638,1,4,0)
 ;;=4^Z65.8
 ;;^UTILITY(U,$J,358.3,7638,2)
 ;;=^5063185
 ;;^UTILITY(U,$J,358.3,7639,0)
 ;;=Z86.11^^42^499^115
 ;;^UTILITY(U,$J,358.3,7639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7639,1,3,0)
 ;;=3^Personal Hx of Tuberculosis
 ;;^UTILITY(U,$J,358.3,7639,1,4,0)
 ;;=4^Z86.11
 ;;^UTILITY(U,$J,358.3,7639,2)
 ;;=^5063461
 ;;^UTILITY(U,$J,358.3,7640,0)
 ;;=Z86.13^^42^499^82
 ;;^UTILITY(U,$J,358.3,7640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7640,1,3,0)
 ;;=3^Personal Hx of Malaria
 ;;^UTILITY(U,$J,358.3,7640,1,4,0)
 ;;=4^Z86.13
 ;;^UTILITY(U,$J,358.3,7640,2)
 ;;=^5063463
 ;;^UTILITY(U,$J,358.3,7641,0)
 ;;=Z86.73^^42^499^112
 ;;^UTILITY(U,$J,358.3,7641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7641,1,3,0)
 ;;=3^Personal Hx of TIA & Cereb Infrc w/o Residual Deficits
 ;;^UTILITY(U,$J,358.3,7641,1,4,0)
 ;;=4^Z86.73
 ;;^UTILITY(U,$J,358.3,7641,2)
 ;;=^5063477
 ;;^UTILITY(U,$J,358.3,7642,0)
 ;;=Z86.79^^42^499^75
 ;;^UTILITY(U,$J,358.3,7642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7642,1,3,0)
 ;;=3^Personal Hx of Circulatory System Diseases
 ;;^UTILITY(U,$J,358.3,7642,1,4,0)
 ;;=4^Z86.79
 ;;^UTILITY(U,$J,358.3,7642,2)
 ;;=^5063479
 ;;^UTILITY(U,$J,358.3,7643,0)
 ;;=Z91.040^^42^499^64
 ;;^UTILITY(U,$J,358.3,7643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7643,1,3,0)
 ;;=3^Latex Allergy Status
 ;;^UTILITY(U,$J,358.3,7643,1,4,0)
 ;;=4^Z91.040
 ;;^UTILITY(U,$J,358.3,7643,2)
 ;;=^5063607
 ;;^UTILITY(U,$J,358.3,7644,0)
 ;;=Z98.89^^42^499^120
 ;;^UTILITY(U,$J,358.3,7644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7644,1,3,0)
 ;;=3^Postprocedural States/Hx of Surgery NEC
 ;;^UTILITY(U,$J,358.3,7644,1,4,0)
 ;;=4^Z98.89
 ;;^UTILITY(U,$J,358.3,7644,2)
 ;;=^5063754
 ;;^UTILITY(U,$J,358.3,7645,0)
 ;;=Z92.3^^42^499^79
 ;;^UTILITY(U,$J,358.3,7645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7645,1,3,0)
 ;;=3^Personal Hx of Irradiation
 ;;^UTILITY(U,$J,358.3,7645,1,4,0)
 ;;=4^Z92.3
 ;;^UTILITY(U,$J,358.3,7645,2)
 ;;=^5063637
 ;;^UTILITY(U,$J,358.3,7646,0)
 ;;=Z91.120^^42^499^60
 ;;^UTILITY(U,$J,358.3,7646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7646,1,3,0)
 ;;=3^Intentional Underdose of Meds d/t Financial Hardship
 ;;^UTILITY(U,$J,358.3,7646,1,4,0)
 ;;=4^Z91.120
 ;;^UTILITY(U,$J,358.3,7646,2)
 ;;=^5063612
 ;;^UTILITY(U,$J,358.3,7647,0)
 ;;=Z91.11^^42^499^69
 ;;^UTILITY(U,$J,358.3,7647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7647,1,3,0)
 ;;=3^Noncompliance w/ Dietary Regimen
 ;;^UTILITY(U,$J,358.3,7647,1,4,0)
 ;;=4^Z91.11
 ;;^UTILITY(U,$J,358.3,7647,2)
 ;;=^5063611
 ;;^UTILITY(U,$J,358.3,7648,0)
 ;;=Z87.891^^42^499^103
 ;;^UTILITY(U,$J,358.3,7648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7648,1,3,0)
 ;;=3^Personal Hx of Nicotine Dependence
 ;;^UTILITY(U,$J,358.3,7648,1,4,0)
 ;;=4^Z87.891
 ;;^UTILITY(U,$J,358.3,7648,2)
 ;;=^5063518
 ;;^UTILITY(U,$J,358.3,7649,0)
 ;;=Z77.090^^42^499^11
 ;;^UTILITY(U,$J,358.3,7649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7649,1,3,0)
 ;;=3^Asbestos Contact/Exposure
 ;;^UTILITY(U,$J,358.3,7649,1,4,0)
 ;;=4^Z77.090
